Publications

LSHTM

Found 0 results for your search. Showing 0 to 0.

No results could be found for your search.

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Letter to the editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies.

ARASHIRO, T; Arima, Y; Kuramochi, J; Muraoka, H; Sato, A; Chubachi, K; Oba, K; Yanai, A; Arioka, H; Uehara, Y; Ihara, G; Kato, Y; Yanagisawa, N; Nagura, Y; Yanai, H; Ueda, A; Numata, A; Kato, H; Oka, H; Nishida, Y; Ooki, T; Nidaira, Y; Stucky, A; Suzuki, T; SMITH, C; ... Suzuki, M.

2023

Eurosurveillance, (2023).28 4 10.2807/1560-7917.ES.2023.28.4.2300034.

Difficulty accessing condoms because of the COVID-19 pandemic reported by gay, bisexual and other men who have sex with men in the UK: findings from a large, cross-sectional, online survey.

Brown, JR; Reid, D; Howarth, AR; Mohammed, H; Saunders, J; Pulford, CV; Ogaz, D; HUGHES, G; Mercer, CH;

2023

International journal of STD & AIDS, (2023).34 8 10.1177/09564624231160804.

Consumption and tax gains attributable to Covid-19 vaccinations in 12 EU countries with low vaccination rates.

Cylus, J; Walters, J; MCKEE, M; Cowley, P;

2023

European journal of public health, (2023).33 2 10.1093/eurpub/ckad023.

Are People with Disabilities at Higher Risk of COVID-19-Related Mortality?: A Systematic Review and Meta-Analysis.

Kuper, H; SMYTHE, T;

2023

SSRN (2023). 10.2139/ssrn.4356773.

Why are people with intellectual disabilities clinically vulnerable to COVID-19?.

KUPER, H; SCHERER, N;

2023

The Lancet. Public health, (2023).8 5 10.1016/s2468-2667(23)00077-4.

Health system adaptions to improve care for people living with non-communicable diseases during COVID-19 in low-middle income countries: A scoping review.

Baatiema, L; Sanuade, OA; ALLEN, LN; Abimbola, S; Hategeka, C; Koram, KA; Kruk, ME;

2023

Journal of global health, (2023).13, 10.7189/iogh.13.06006.

The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium.

Daynes, E; Baldwin, M; Greening, NJ; Yates, T; Bishop, NC; Mills, G; Roberts, M; Hamrouni, M; Plekhanova, T; Vogiatzis, I; Echevarria, C; Nathu, R; McAuley, HJ C; Latimer, L; Glennie, J; Chambers, F; Penfold, R; Hume, E; Megaritis, D; Alexiou, C; Potthoff, S; Hogg, MJ; Haighton, C; Nichol, B; Leavy, OC; ... Singh, SJ.

2023

Trials, (2023).24 1 10.1186/s13063-023-07093-7.

Gendered Experiences of COVID-19 Vaccination in Freetown: A Qualitative Study in Portee-Rokupa Community.

Conteh, A; Sesay, IJ; Macarthy, J; Koroma, B; Priddy, C; ENRIA, L;

2023

(2023).

Essential emergency and critical care as a health system response to critical illness and the COVID19 pandemic: what does it cost?.

GUINNESS, L; Kairu, A; Kuwawenaruwa, A; Khalid, K; Awadh, K; Were, V; Barasa, E; Shah, H; Baker, P; Schell, CO; Baker, T;

2023

Cost effectiveness and resource allocation, (2023).21 1 10.1186/s12962-023-00425-z.

High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020-April 2021), Democratic Republic of the Congo.

Munyeku-Bazitama, Y; Folefack, GT; Yambayamba, MK; Tshiminyi, PM; Kazenza, BM; Otshudiema, JO; Guinko, NT; Umba, MD; Mulumba, A; Baketana, LK; Mukadi, PK; SMITH, C; Muyembe-Tamfum, J-J; Ahuka-Mundeke, S; Makiala-Mandanda, S;

2023

Emerging Infectious Diseases, (2023).29 1 10.3201/eid2901.221009.